Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

3 Penny Stocks Insiders Are Buying

Author: Lisa Levin | January 13, 2022 08:42am

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Performant Financial

  • The Trade: Performant Financial Corporation (NASDAQ:PFMT) 10% owner Phil Frohlich acquired a total of 40899 shares at an average price of $2.06. To acquire these shares, it cost $84,251.94.
  • What’s Happening: Performant Financial recently announced a $35 million debt refinancing.
  • What Performant Financial Does: Performant Financial Corp provides technology-enabled recovery and related analytics services in the United States.

ServiceSource International

  • The Trade: ServiceSource International, Inc. (NASDAQ:SREV) 10% owner Jonathan Brolin acquired a total of 35332 shares at an average price of $1.04. The insider spent $36,691.34 to buy those shares.
  • What’s Happening: The company’s stock gained around 4% over the past month.
  • What ServiceSource International Does: ServiceSource International Inc is a provider of customer and revenue lifecycle management solutions.

Anixa Biosciences

  • The Trade: Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Lewis H. Titterton Jr. acquired a total of 2000 shares at an average price of $3.20. To acquire these shares, it cost $6,400.00.
  • What’s Happening: Anixa Biosciences, last month, announced the results of a genomic variant analysis conducted with its partner, MolGenie GmbH, on potential compounds to treat COVID-19.
  • What Anixa Biosciences Does: Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the body's immune system in the fight against cancer.

Posted In: ANIX PFMT SREV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist